VivoSeq
Other

Minocycline

0

Pipeline Programs↗

1

Active Trials↗

7

Companies Involved↗

Minocycline is an early-stage landscape with 0 programs across 7 companies. The most active players are Vyne Therapeutics Inc., GSK, Melinta Therapeutics, Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Vyne Therapeutics Inc.

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalM

Melinta Therapeutics, Inc.

0 programs

PreclinicalA

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

0 programs

PreclinicalH

Helperby Therapeutics Ltd

0 programs

PreclinicalM

Medicis Pharmaceutical Corporation

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

39

clinical trials

Completed27 · 69%
Unknown status7 · 18%
Terminated4 · 10%
Not yet recruiting1 · 3%

Clinical Trials

Trial Activity

39 trials

Topical Minocycline for CARP
Not yet recruiting·MMedical University of South Carolina·Phase 1·NCT07462702·35 enrolled
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
Completed·VVyne Therapeutics Inc.·Phase 2·NCT04104685·446 enrolled
Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions
Completed·RRanbaxy Laboratories Limited·N/A·NCT00777413·24 enrolled
A Pharmacokinetic Study of Minocycline in Male and Female Volunteers
Completed·VVyne Therapeutics Inc.·Phase 1·NCT02250859·12 enrolled
Open Treatment of Minocycline in Geriatric Depression
Completed·WWeill Medical College of Cornell University·N/A·NCT01659320·16 enrolled
Bioequivalence Minocycline Bioequivalence
Completed·GSK logoGSK·Phase 1·NCT01755611·25 enrolled
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
Completed·MMelinta Therapeutics, Inc.·Phase 1·NCT02802631·69 enrolled
Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg
Completed·UUniversity of Minnesota·Phase 4·NCT03762915·70 enrolled
The Effects of Minocycline in Humans
Completed·YYale University·Phase 1·NCT02193269·10 enrolled
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Completed·MM.D. Anderson Cancer Center·Phase 2·NCT01906008·122 enrolled
Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions
Completed·RRanbaxy Laboratories Limited·N/A·NCT02312609·18 enrolled
Minocycline in Clinically Isolated Syndromes (CIS)
Completed·—·Phase 3·NCT00666887·142 enrolled
Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas
Completed·HHelperby Therapeutics Ltd·Phase 4·NCT02030912·42 enrolled
Minocycline to Reduce Pain After Carpal Tunnel Release
Completed·VVA Palo Alto Health Care System·Phase 2·NCT02051296·131 enrolled
Minocycline Bioequivalence Study
Completed·GSK logoGSK·Phase 1·NCT01938508·28 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)